• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Ed Chapman
Ed Chapman
Ed Chapman

Ed Chapman

Partner

  • London UK
Contact Me Today
+44 20 7300 7014
vCard
Email me Call me

Ed is a partner in our Corporate team and dual-qualified in England and Wales and California. He advises clients on strategic buy and sell-side M&A transactions, venture capital and growth equity financings, joint ventures, and restructurings, particularly within the technology and life sciences sectors.

Ed has extensive experience structuring, negotiating, and executing complex domestic and cross-border matters, regularly working across the UK, Europe, Nordics, and North America.

Ed is noted as a 'Key Lawyer' for mid-market M&A deals by Legal 500 UK 2025 and praised by clients for providing "the most exceptional service … always [going] above and beyond".

Expertise

Services and Groups

Corporate/M&A & capital markets
Venture capital
Private equity
Environmental, social & governance (ESG)
General corporate
Joint ventures
Start-up advice
M&A

Sectors

Technology, media & communications
Life sciences & healthcare
Our USA offering

Over the past 10 years, we've built a trusted legal team in San Francisco, focused on technology, media and communciation, life sciences and healthcare, real estate, private wealth, and private equity. Supported by colleagues in the UK and Europe, we also offer deep expertise in M&A, international growth, commercial deals, and data privacy.

Find out more

A guide to transatlantic M&A for US buyers

A guide to transatlantic M&A for US buyers

A comprehensive guide to acquiring a business based in the UK or Europe. 

Access the guide

Founders Exit Guide

Selling your business: a guide for founders and management teams

A comprehensive guide to preparing your business for sale.

Find out more

CV

Since 2023 Partner, Taylor Wessing
2020 - 2023 Senior Associate, Taylor Wessing
2014 - 2020 Associate, Slaughter and May
2012 – 2014 Trainee Solicitor, Slaughter and May
2024 Admitted to the State Bar, California
2014 Admitted as a Solicitor, England and Wales
2012 Legal Practice Course (Distinction), BPP London
2011 Graduate Diploma in Law (Distinction), BPP London
2009 MA in Classics and Ancient History (Distinction), University of Bristol
2008 BA in Ancient History (First Class Honours), University of Bristol

Career

Since 2023 Partner, Taylor Wessing
2020 - 2023 Senior Associate, Taylor Wessing
2014 - 2020 Associate, Slaughter and May
2012 – 2014 Trainee Solicitor, Slaughter and May

Education

2024 Admitted to the State Bar, California
2014 Admitted as a Solicitor, England and Wales
2012 Legal Practice Course (Distinction), BPP London
2011 Graduate Diploma in Law (Distinction), BPP London
2009 MA in Classics and Ancient History (Distinction), University of Bristol
2008 BA in Ancient History (First Class Honours), University of Bristol

Experience

Advising on Draig Therapeutics' US$140 million series A financing

We have advised a syndicate of leading global life sciences investors including Access Biotechnology, Canaan Partners and SR One on their landmark US$140 million series A investment in Draig Therapeutics.

Press release
Ross McNaughton
Elinor Picton
Oli Denne
Helen Farr
Adrian Toutoungi
Charlie Adams
Nicholas Vollers
Ed Chapman

Ed's news & insights

View Ed's insights
Close-Up Of Shopping Cart
Click here to find out more
Corporate/M&A & capital markets

Advising Sofina Foods on its acquisition of Finnebrogue

10 July 2025

by Ed Chapman and Jack Coventry

Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising on Draig Therapeutics' US$140 million series A financing

23 June 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising Grant Thornton UAE on its business combination with Grant Thornton Advisors LLC

24 April 2025

by multiple authors

Click here to find out more
View Ed's insights

Related news & insights

Update from Berlin: Federal government tightens cannabis policy

8 January 2026
Briefing

by Kathleen Munstermann-Senff, LL.M. (Medical Law) and Dr. Martin Jäger

Click here to find out more
Paper craft brain
Life sciences & healthcare

The European Innovation Act: From Regulatory Fragmentation to Coherent Innovation Governance

5 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Netherlands

Partner appointment Margot van Gerwen

5 January 2026

by Margot van Gerwen

Click here to find out more
Lights on network server
Life sciences & healthcare

Data Provision under the Data Act in the Life Sciences Environment

5 January 2026
In-depth analysis

by Dr. Julia Freifrau von Imhoff and Dr. Christian Frank, Licencié en droit (Paris II / Panthéon-Assas)

Click here to find out more
Close up of a walnut
Life sciences & healthcare

EUDAMED-Rollout: From a Perpetual Construction Site to Regulatory Reality

5 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Data centre server room
Life sciences & healthcare

Everything Is Relative? Implications of the CJEU Judgment C-413/23 (SRB/EDPS) for the Secondary Use of Personal Data in Research Practice

5 January 2026
In-depth analysis

by Stephanie Richter, LL.M. (Torino), CIPP/E

Click here to find out more
office at night
Corporate/M&A & capital markets

Taylor Wessing advises Andreessen Horowitz and Index Ventures on US$41 million seed financing of Mirelo AI

23 December 2025

by multiple authors

Click here to find out more
Close-Up Of Shopping Cart
Commercial & consumer contracts

Product safety for consumer products: New EU guidelines from November 2025

22 December 2025
Briefing

by Dr. Benedikt Rohrßen and Dr. Ulrich Spiegel

Click here to find out more
Inside the Office Building
Corporate/M&A & capital markets

Taylor Wessing advises Accel and other existing shareholders on Trade Republic's €1.2 billion secondary round

22 December 2025

by multiple authors

Click here to find out more
Close up of a walnut on grey background
UPC

Pre-trial discovery before the UPC? – Pharmaceuticals, Trade fairs and beyond

19 December 2025
In-depth analysis

by multiple authors

Click here to find out more
View all insights

Related people

UK
Global
Oli Denne

Oli Denne

Senior Associate

Cambridge
+44 1223 446 400
Email me
View profile
Philip Shepherd

Philip Shepherd

Partner

London
+44 20 7300 4655
Email me
View profile
Ian Moore

Ian Moore

Partner

London
+44 20 7300 4664
Email me
View profile

Edward Waldron

Partner

London
+44 (0)20 7300 4968
Email me
View profile
Liz Wilson

Liz Wilson

Partner

London
+44 20 7300 4979
Email me
View profile
Tom Charnley

Tom Charnley

Senior Counsel

Liverpool
London
+44 20 7300 7000
Email me
View profile
Richard Faichney

Richard Faichney

Partner

London
+44 207 300 4773
Email me
View profile

Debbie Cloake

Senior Counsel – Knowledge

London
+44 20 7300 7000
Email me
View profile
Bryce Bartlett

Bryce Bartlett

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Meg Burton

Meg Burton

Senior Counsel

London
San Francisco
+44 20 7300 7000
Email me
View profile
Full team
Karolina Lange

Karolina Lange-Kulmann, LL.M. (Medizinrecht)

Partner

Duesseldorf
+49 211 8387 0
Email me
View profile
Bridget Winters

Bridget Winters

Senior Counsel

London
+44 20 7300 7000
Email me
View profile
Sebastian Beyer

Dr. Sebastian Beyer, LL.M. (Auckland)

Salary Partner

Frankfurt
Duesseldorf
+49 69 97130 135
Email me
View profile
Marc-Oliver Kurth, Corporate M&A Lawyer in Berlin | Taylor Wessing

Marc-Oliver Kurth, LL.M. (Sydney)

Partner

Berlin
Frankfurt
+49 30 885636 421
Email me
View profile
Rob Hendriks

Rob Hendriks, Dr.

Partner

Amsterdam
+31 88 02 43 289
Email me
View profile
Xiaowen Paulus-Ye

Xiaowen Paulus-Ye

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Bram Nijhof

Bram Nijhof

Partner

Eindhoven
Brussels
+31 88 02 43 113
Email me
View profile
Daniël Soons

Daniël Soons

Associate

Amsterdam
+31 88 024 3193
Email me
View profile
Andrew Telling

Andrew Telling

Head of Knowledge

London
+44 20 7300 7000
Email me
View profile
Erena-Sarah

Sarah Erena

Associate

Paris
+33 1 72 74 03 33
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing